Dr. Ravi Ramessur

Dr. Ravi Ramessur is a Consultant Clinical-Academic Dermatologist dedicated to providing comprehensive, holistic care while ensuring his patients have access to the most advanced and effective treatments. He balances his private practice with his continued role as an NHS consultant, offering his expertise across both settings.

Dr. Ramessur has a specialist interest in inflammatory skin conditions, including psoriasis, eczema, acne and rosacea. He also has extensive experience in diagnosing and managing warts, cysts, mole checks, vitiligo and skin cancer, consulting with both children and adults.

He completed his medical training at the University of Cambridge and the University of Oxford before undertaking specialist dermatology training in London and Cambridge. Following his dermatology training, he pursued a PhD at the St John’s Institute of Dermatology in London, focusing on the impact of lifestyle factors and genetics on psoriasis and its related health issues.

Dr. Ramessur’s clinical and research work has earned him numerous national and international awards. He has published over 20 peer-reviewed articles, including contributions to high-impact journals such as The Lancet, JAMA Cardiology, and the British Journal of Dermatology. He is frequently invited to present his findings at major international conferences. Since 2023, he has been invited to give talks at scientific meetings in Amsterdam, Brussels, Dubai, Freiberg, Glasgow, Liverpool, London, Madrid, New Orleans, Oslo, Paris, San Diego, Singapore, Southampton, Tokyo, and Trondheim.

Beyond clinical practice, Dr. Ramessur is committed to advancing dermatology and healthcare more broadly through active roles in several key national organisations, including:

National Institute for Health and Care Excellence (NICE)

Technology Appraisal Committee: Ensuring new medical treatments are effective and cost-efficient for NHS use.

British Association of Dermatologists (BAD)

Therapeutics and Guidelines Subcommittee: Developing evidence-based recommendations for treating skin conditions to ensure safe and effective patient care.
Artificial Intelligence Working Party: Exploring the potential of artificial intelligence to enhance the diagnosis and treatment of skin conditions.
Audit Subcommittee: Overseeing quality improvement initiatives to ensure high standards of dermatology care across the UK.

Dr. Ravi Ramessur's Publications(7)

Dr Ramessur’s publications include:

Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective

Ramessur R, Dand N, Langan SM, Saklatvala J, Fritzsche MC, Holland S, Arents BWM, McAteer H, Proctor A, McMahon D, Greenwood M, Buyx AM, Messer T, Weiler N, Hicks A, Hecht P, Weidinger S, Ndlovu MN, Chengliang D, Hübenthal M, Egeberg A, Paternoster L, Skov L, De Jong EMGJ, Middelkamp-Hup MA, Mahil SK, Barker JN, Flohr C, Brown SJ, Smith CH

British Journal of Dermatology

Exploring the Link Between Genetic Predictors of Cardiovascular Disease and Psoriasis

Ramessur R, Saklatvala J, Budu-Aggrey A, Ostaszewski M, Möbus L, Greco D, Ndlovu M, Mahil SK, Barker JN, Brown S, Paternoster L, Dand N, Simpson MA, Smith CH

JAMA Cardiology

New analyses exploring multimorbidity in psoriasis

Nick Dand, Ravi Ramessur

British Journal of Dermatology

Glomovenous malformation secondary to a heterozygous nonsense variant in GLMN: a clinical mimicker of blue rubber bleb naevus syndrome

Ravi Ramessur, Tamara Fadhli, Bharati Tripathi, Daisy Sandhu, Kapila Batta

Clinical and Experimental Dermatology

Biomarkers of disease progression in people with psoriasis: a scoping review

Ravi Ramessur, Mark Corbett, David Marshall, Marcio Acencio, Ines Biscaia De Andrade Barbosa, Nick Dand, Paola Di Meglio, Salma Haddad, Andreas Jensen, Witte Koopmann, Satveer Mahil, Marek Ostaszewski, Seher Rahmatulla, Joe Rastrick, Jake Saklatvala, Stephan Weidinger, Kath Wright, Kilian Eyerich, Matladi Ndlovu, Jonathan BarkerLone Skov, Curdin Conrad, Catherine Smith

British Journal of Dermatology

Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis

Konstantinos Douroudis, Ravi Ramessur, Ines A. Barbosa, David Baudry, Michael Duckworth, Caroline Angit, Francesca Capon, Raymond Chung, Charles J. Curtis, Paola Di Meglio, Jonathan M.R. Goulding, Christopher E.M. Griffiths, Sang Hyuck Lee, Satveer K. Mahil, Richard Parslew, Nick J. Reynolds, Alexa R. Shipman, Richard B. Warren, Zenas Z.N. Yiu, Michael A. Simpson, Jonathan N. Barker, Nick Dand, Catherine H. Smith

Journal of Investigative Dermatology

Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination

Ravi Ramessur, Nawar Saffar, Branislav Czako, Anju Aggarwal, Kapila Batta

Clinical and Experimental Dermatology

Get in touch

One of our friendly staff will be delighted to help with your enquiry.

0207 901 8500

Or send us an enquiry

Related Consultants